The optimal therapy for<unk>  T-cell leukemia depends on the clinical variant of the disease. Chronic and smoldering<unk>  T-cell leukemia patients are usually managed by either observation, skin directed therapies, or a combination of zidovudine and interferon therapy. Acute<unk>  T-cell leukemia patients are usually managed by either chemotherapy, supportive care, allogeneic stem<unk>  transplant, or a combination of zidovudine and interferon therapy. The first line chemotherapeutic regimens used for the initial management of<unk>  T-cell leukemia include CHOP, CHOEP, or Dose-adjusted EPOCH. Second line chemotherapeutic agents might be DHAP, ESHAP, GDP, GemOx, or ICE.
Adult T-cell leukemia medical therapy
Hairy cell leukemia medical therapy
Chronic lymphocytic leukemia medical therapy
Myeloproliferative neoplasm medical therapy
Acute lymphoblastic leukemia medical therapy
Acute myeloid leukemia medical therapy
Chronic myelogenous leukemia medical therapy
Acute promyelocytic leukemia medical therapy